Comparing Farxiga vs Januvia
Farxiga (dapagliflozin) | Januvia (sitagliptin) |
|
---|
Farxiga (dapagliflozin) | Januvia (sitagliptin) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Farxiga is an oral medication that is used alongside diet and exercise to lower blood glucose levels in adults and children aged 10 years and older with type 2 diabetes. It may also be used to... View more |
Prescription only
Januvia is a DPP-4 inhibitor that is used in addition to other medications for the treatment of type 2 diabetes. Rarely, it may cause joint pain, skin reactions, pancreatitis, or an allergic... View more |
Related suggestions Type 2 Diabetes
|
|||||||
More about Farxiga (dapagliflozin) | More about Januvia (sitagliptin) | ||||||||
Ratings & Reviews | |||||||||
Farxiga has an average rating of 4.6 out of 10 from a total of 162 ratings on Drugs.com. 26% of reviewers reported a positive effect, while 47% reported a negative effect. |
Januvia has an average rating of 4.5 out of 10 from a total of 139 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 53% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Farxiga side effects |
View all Januvia side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Farxiga prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
N/A |
Other sitagliptin brands include: Brynovin, Zituvio | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
12.9 hours |
12.4 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 372 drugs are known to interact with Farxiga:
|
A total of 295 drugs are known to interact with Januvia:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
January 08, 2014 |
October 16, 2006 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.